CRISPR Therapeutics AG
← Back to CRSP Overview

CRISPR Therapeutics AG (CRSP)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-9.29

Financial Fundamentals

CRSP • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2015-03-31-3.87
2015-06-30-5.34
2015-09-30-16.01
2015-12-31-8.39
2016-03-31-12.15
2016-06-30-8.19
2016-09-30-9.52
2016-12-3111.78
2017-03-31-10.08
2017-06-30-7.15
2017-09-30-7.21
2017-12-311893.55
2018-03-31-18.43
2018-06-30-17.91
2018-09-30-9.89
2018-12-31-7.76
2019-03-31-9.53
2019-06-30-11.81
2019-09-304.07
2019-12-3128.73
2020-03-31-9.22
2020-06-30-14.13
2020-09-30-15.84
2020-12-31-25.02
2021-03-31-20.17
2021-06-304.04
2021-09-30-16.76
2021-12-31-10.30
2022-03-31-6.76
2022-06-30-6.33
2022-09-30-7.29
2022-12-31-7.21
2023-03-31-16.88
2023-06-30-14.32
2023-09-30-8.05
2023-12-3113.97
2024-03-31-11.92
2024-06-30-9.05
2024-09-30-11.63
2024-12-31-22.36
2025-03-31-5.38
2025-06-30-5.07
2025-09-30-13.85
2025-12-31-9.57
2026-03-31-9.29

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.